Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
LONDON, UNITED KINGDOM: Hikma Pharmaceuticals has acquired an undiscosed minority interest in Hubei Haosun Pharmaceutical, based in China, through the subscription of new equity for a cash consideration of $5 million.
Haosun, a privately held company, develops and manufacturers niche active pharmaceutical ingredients (API) with a specialization in oncology APIs. Haosun’s current product portfolio and development pipeline, which covers a range of therapeutic areas, fits well with Hikma’s requirements.
Through this partnership Hikma says it gains access to a high quality, long term source of APIs, particularly in the strategically important area of oncology. The transaction demonstrates the continuation of Hikma’s strategy of enhancing its API sourcing and R&D capabilities in key product areas, the company said.
© WOC News
Login
CONSHOHOCKEN, US: Quaker Chemical Corporation has acquired the remaining ownership interest in its Mexican affiliate, TecniQuimia Mexicana, SA de CV. ...
To list shares on NYSE under symbol ‘MRD’ Credit Suisse, Morgan Stanley, Deutsche Bank to lead offering To use proceeds to red ...
ARGONNE, US: Researchers at the US Department of Energy’s Argonne National Laboratory and Northwestern University have identified a new biologic ...
HEERLEN, THE NETHERLANDS: Royal DSM N V has acquired a 51 per cent stake in AGI Corporation of Taiwan through a subscription for newly to be issued sh ...
New MIT-developed materials make it possible to produce photovoltaic cells on paper or fabric, nearly as simply as printing a document. CAMBRIDGE, US ...
PARIS, FRANCE: Technip is awarded an engineering services contract by Solvay in China. This is for the construction of the previously announced epichl ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder